Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON22342Not yet recruiting
Randomised trial of chloroprocaine, bupivacaine and sufentanil (4 arms), sponsored by UZ Brussel. Primary endpoint: Earlier relief of motor block. Planned start Jul 2013; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON22342.